Intra-Abdominal Photodynamic Therapy in a Rabbit Model of Perforated Appendicitis

Abstract

Insights

Methylene blue photodynamic therapy (MB-PDT) is safe and feasible for treating perforated appendicitis in rabbits. While not reducing bacterial burden in vivo, it showed strong in vitro efficacy, suggesting potential for intra-abdominal infections.

Area of Science:

  • Surgical Innovation
  • Antimicrobial Therapy
  • Preclinical Research

Background:

  • Perforated appendicitis in children often requires prolonged antibiotics.
  • Current intraoperative antimicrobial options are limited.
  • Photodynamic therapy (PDT) offers a targeted, resistance-independent approach.

Purpose of the Study:

  • To assess the feasibility, safety, and preliminary efficacy of laparoscopic methylene blue photodynamic therapy (MB-PDT).
  • To evaluate MB-PDT for intra-abdominal disinfection in a rabbit model of perforated appendicitis.

Main Methods:

  • Nineteen rabbits underwent induced perforated appendicitis and peritonitis.
  • Laparoscopic MB-PDT was administered 24-40 hours post-perforation.
  • Outcomes included PDT delivery feasibility, safety (histology), and bacterial burden changes (in vivo and in vitro).

Main Results:

  • Laparoscopic MB-PDT was feasible and safe, with no off-target histologic injury.
  • In vivo bacterial burden did not significantly decrease (p=0.18).
  • In vitro MB-PDT demonstrated significant bacterial reduction (p<0.001), especially for Gram-positive bacteria.

Conclusions:

  • Laparoscopic MB-PDT is a safe and feasible adjunct for perforated appendicitis in a preclinical model.
  • High in vitro efficacy supports further investigation for intra-abdominal infections.
  • Further research is warranted to optimize in vivo efficacy.